scholarly article | Q13442814 |
P50 | author | Lynne Mofenson | Q43882680 |
William T. Shearer | Q45453692 | ||
Steven Colan | Q57424879 | ||
George Seage | Q90086356 | ||
James Dean Wilkinson | Q91486147 | ||
Paige L Williams | Q92245374 | ||
Jonathan R Kaltman | Q95989849 | ||
Bret Zeldow | Q101570584 | ||
George K Siberry | Q114404939 | ||
Laurie B Dooley | Q117266957 | ||
Pediatric HIVAIDS Cohort Study (PHACS) | Q117266959 | ||
P2093 | author name string | Steven E Lipshultz | |
Kenneth C Rich | |||
Russell B van Dyke | |||
P2860 | cites work | Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group | Q28239283 |
No adjustments are needed for multiple comparisons | Q28292261 | ||
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues | Q28373514 | ||
Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine | Q28378182 | ||
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
Lipoprotein particle subclasses, cardiovascular disease and HIV infection. | Q33639078 | ||
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial | Q33873955 | ||
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission | Q33958839 | ||
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV | Q34036150 | ||
Cardiac biomarkers in HIV-exposed uninfected children | Q34081675 | ||
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States | Q35075011 | ||
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). | Q35626381 | ||
Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. | Q35732636 | ||
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers | Q36077016 | ||
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1 | Q36441790 | ||
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children | Q36800856 | ||
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity | Q37378238 | ||
Viral myocarditis: diagnosis, aetiology and management | Q37543413 | ||
Cardiovascular magnetic resonance of myocarditis | Q37738259 | ||
Prenatal ethanol exposure alters ventricular myocyte contractile function in the offspring of rats: influence of maternal Mg2+ supplementation. | Q44127078 | ||
Empirical-Bayes adjustments for multiple comparisons are sometimes useful | Q44399723 | ||
Influence of chronic intrauterine exposure to alcohol on structurally normal hearts | Q44572212 | ||
Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine | Q44786396 | ||
QT prolongation in the newborn and maternal alcoholism | Q45243808 | ||
Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study | Q50142446 | ||
Alcohol in pregnancy and fetal heart damage | Q52265026 | ||
Theoretical and empirical derivation of cardiovascular allometric relationships in children. | Q53840332 | ||
Myocarditis | Q55953402 | ||
The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: Design and methods | Q57996846 | ||
Absence of Cardiac Toxicity of Zidovudine in Infants | Q61698885 | ||
Mitochondrial function in children with idiopathic dilated cardiomyopathy. | Q64916264 | ||
Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy | Q71322855 | ||
Teratogenic effects of ethanol during hyperplastic growth in cardiac myocyte cultures | Q72702513 | ||
Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility | Q72745852 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 91-100 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers | |
P478 | volume | 29 |
Q37691000 | Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children |
Q35898974 | Cardiac Effects of Antiretroviral-Naïve versus Antiretroviral-Exposed HIV Infection in Children |
Q63816197 | Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children |
Q64040134 | Cardiac and mitochondrial function in HIV-uninfected fetuses exposed to antiretroviral treatment |
Q38846571 | Complications of Treatment in Youth with HIV. |
Q38716857 | Fetal Metabolic Stress Disrupts Immune Homeostasis and Induces Proinflammatory Responses in Human Immunodeficiency Virus Type 1- and Combination Antiretroviral Therapy-Exposed Infants |
Q29109559 | Genetically determined ancestry is more informative than self-reported race in HIV-infected and -exposed children |
Q35594678 | In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial |
Q39565701 | Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies |
Q36395153 | Paediatric HIV: Progress on Prevention, Treatment and Cure |
Q91619640 | Peripheral blood mononuclear cell transcriptomes reveal an over-representation of down-regulated genes associated with immunity in HIV-exposed uninfected infants |
Q26744617 | The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs |